AbbVie Inc. (ABBV) is a global biopharmaceutical company headquartered in North Chicago, Illinois. It discovers, develops, manufactures, and commercializes medicines across immunology, oncology, neuroscience, eye care, and medical aesthetics. The company operates internationally, combining research, clinical development, production, and commercial capabilities to address complex diseases and expand its treatment portfolio. It has a market capitalization of $500.94 billion.
The company is expected to report its third-quarter results for fiscal 2026 on Oct. 30, before the market opens. Ahead of the release, Wall Street analysts are optimistic about the company’s bottom-line trajectory.